Active
On

Why factor investing keeps disappointing

Due to a sustained period of underperformance, investors are increasingly questioning the validity of factor investing. Georg Elsaesser, Portfolio Manager Quantitative Investment at Invesco, has a simple explanation for the underperformance, and is not worried, yet.

‘The value factor and small-caps in particular have done badly, but that can be explained by the market environment. All factors are still doing what they are supposed to do,’ says Elsaesser.

Coronavirus leads to EM of two paces

The performance gap between East Asia and other emerging markets has never been greater than in the first five months of 2020. At first sight, the cause looks obvious: coronavirus. But in the background there is a different dynamic at play.

Ironically, the ranking of best-performing stock markets in 2020 is led by China, the country where the pandemic originated. Korea and Taiwan are also well on their way, and in any case doing much better than most other emerging markets (see graph below).

Luxflag webinar: ‘Pandemic increases need for ESG disclosure’

The coronavirus outbreak has increased the need for more granular ESG data. However, such data are still difficult to collect as they are often not disclosed by companies. This needs to change fast in anticipation of upcoming EU rules, said participants in a webinar on the topic organised by Luxflag on Wednesday.  

‘Short but fierce value rally ahead’

The difference in valuations between expensive and cheap stocks has overshot in recent weeks. Investors can therefore expect a period of outperformance of value stocks. However, this will not last too long. 

Investors’ asset allocation consensus now seems stronger than it has ever been. Pretty much all investors are overweight in quality and growth stocks, avoiding the sectors most affected by the corona crisis.